Delta, Kelowna, BC – May 29, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM – cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts, #Cannabis News and Stocks on the Move May 29th (CSE: PLTH) (TSXV: OGI) (CSE: VIDA) (TSXV: PCLO) (NEO: HALO)
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
Planet 13 Holdings Inc. (CSE: PLTH) (OTCQB: PLNHF), a leading vertically-integrated Nevada cannabis company, announced today that it has launched Planet M, a line of custom formulated and curated full-spectrum and CBD isolate products. Planet M will have CBD tinctures, edibles, topicals and more.
Planet M will initially be sold at select locations throughout the Fashion Show Mall, the 5th highest grossing mall per sq. ft. in America1. Selected locations in the Fashion Show Mall will promote Planet 13. The Planet 13 Cannabis Entertainment Complex will be home to a 2,000 sq. ft. flagship store featuring educational and experiential components. The flagship CBD store is a part of Phase II construction and is expected to be open in Q3 2019. Planet M will also soon be available online at http://www.planetmcbd.com/ for customers across the United States, where regulation allows. Customers who are introduced to Planet M in Las Vegas at the SuperStore will be able to purchase Planet M even after their vacations are over.
“Over the course of 2019, we will begin to take additional steps to leverage the SuperStore’s growing visibility and unique position as a sales platform, to continue expanding our successful brand portfolio both within Nevada and beyond. Along with our Medizin brand of high THC products, Leaf & Vine which is a high CBD to THC line, and now Planet M a 100% CBD line we have products to meet any need,” said Bob Groesbeck Co-CEO of Planet 13. “Planet M line of CBD products will initially be offered at the SuperStore and the Fashion Show Mall. We will look to expand retail locations over the course of the year, focused initially on the Las Vegas strip where we can drive crossover advertising of the SuperStore and online where we can continue to build our profile across the United States.”
Organigram Holdings Inc. (TSX-V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, announced that it has recently shipped more than one hundred and thirty thousand units of pure cannabidiol (CBD) oil destined for markets across Canada.
The recent legalization of adult-use, recreational cannabis in Canada has resulted in an increased demand for CBD, a naturally occurring compound in cannabis which has no psychoactive effect.
“Since legalization, Canadian consumers have proven themselves to be not only receptive to, but surprisingly well educated about, the benefits of CBD,” says Greg Engel, CEO, Organigram. “Consumers have embraced the idea of cannabis as it relates to overall wellness. While medical patients have long since discovered the potential benefits of CBD, we didn’t anticipate how that awareness would translate into the recreational market but are pleased to be able to help meet this consumer demand.”
Organigram attributes its ability to respond to growing CBD demand in part to the success of its strategic relationships and ongoing inputs from its provincial partners.
As previously announced, Organigram has a long-term agreement in place with 1812 Hemp, a New Brunswick-based industrial hemp research company. Initially, the deal offered Organigram access to approximately 6,000 kg of dried hemp flower harvested in the fall of 2018 which the Company purchased and sent for extraction in the first calendar quarter of 2019. In addition, Organigram has a right-of-first refusal on future procurement of hemp from 1812 Hemp which is expected to increase significantly over 2018 levels in 2019 and beyond.
“The CBD market here in Canada and around the world represents a rapidly growing opportunity,” explains Engel. “At Organigram, we are committed to developing the capacity and relationships that deliver the supply, expertise and quality our customers are looking for while being able to scale up quickly to meet the increasing demand of the global medical and adult recreational cannabis markets.”
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) announced, further to its news release of April 30, 2019, the closing of its acquisition of Canadian e-commerce technology firm, Wikala.com Inc. In connection with the Transaction, David Moon, the Founder of Wikala, has been appointed to the board of directors of the Company, and he will continue to work as the President of Wikala.
“The completion of this transaction marks a new era for Phivida”, said Jim Bailey, President and CEO of Phivida. “This is more than an acquisition of a website – it’s a deal that provides us with Wikala’s team of experts in content creation and search engine optimization (SEO) as well as a captive audience of over 400,000 active users with the ambition to grow it to over 1,000,000 by the first half of 2020.”
Management of Phivida believes that the acquisition of Wikala will provide the Company with an opportunity to accelerate its Oki and Vida+ branded products into the North American market with the addition of Wikala’s e-commerce platform, which is currently in private beta. Combined with the recently launched new feeloki.com website along with the hempvidaplus.com, the Transaction creates a consumer ecosystem that is expected to enhance the visibility of Phivida brands and create further brand loyalty.
PharmaCielo Ltd. (TSXV:PCLO) (OTC:PHCEF) , the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that it has enlisted former U.S. congressman and long-time medical cannabis advocate Dana Rohrabacher as a special advisor to the Company.
“Our team has received accelerated interest from players in several legal U.S. states in recent weeks as the legal structure of medicinal cannabis continues to evolve across the country,” said David Attard, Chief Executive Officer of PharmaCielo. “We believe the U.S. is a significant prospective market for PharmaCielo, particularly on the CBD side in the near term, and we are delighted that Rep. Rohrabacher has agreed to join our team as a special advisor. Rep. Rohrabacher has been one of the most passionate advocates and influential forces in support of legalized medical cannabis in the U.S., and we expect his unparalleled knowledge and experience with understanding the legislative environment to be invaluable to the company for U.S. sales execution.”
Dana Rohrabacher started his political career as President Ronald Reagan’s special assistant and speechwriter. He was elected as a U.S. representative from the state of California District 42 in 1988 and served in Congress for nearly three decades. Rep. Rohrabacher is a well-known advocate for the legalization of medical cannabis and protection of medical cannabis patients’ rights. He was one of the driving forces behind the Rohrabacher-Farr Amendment, pivotal legislation that became a milestone in the legalization of medical cannabis at the crossroads between state and federal levels. Rep. Rohrabacher was also one of the two Republican cofounders of the Congressional Cannabis Caucus.
“As we look at the medicinal benefits of cannabis, with a particular emphasis on its oil extracts, the United States needs to be able to guarantee our citizens have access to the finest products available from the global and domestic communities alike,” said Rep. Rohrabacher. “Having visited the PharmaCielo facilities and seen firsthand the standards to which they produce and process oil extracts, I am very engaged in helping them to understand U.S. federal and state policy and patient medicinal needs, and helping to address those needs in the future while continuing to set high quality standards for the global marketplace overall.”
With the appointment of Dana Rohrabacher as special advisor, PharmaCielo continues to bolster its roster of international advisors to support its expansion into global markets, which has included a number of notable experts including financial expert Jim Rogers, co-founder of the Quantum Fund and Soros Fund Management. Earlier this month, PharmaCielo also announced the establishment of an enhanced Medical and Scientific Advisory Board, a renowned team of international physicians, scientists and researchers led by Dr. Delon Human.
Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) announced that it has partnered with High Tide Inc. (CSE: HITI) (OTCQB: HITIF) to introduce Halo-produced products through High Tide’s distribution channels. High Tide has an extensive distribution network throughout Canada, the United States and Europe with an impressive portfolio of subsidiaries.
The first phase of the collaboration will be a roll-out of in-house DabTabsTM to create a revolutionary product where consumers will receive a do-it-yourself kit in which they can prefill DabTabsTM Tablets with measured doses of either cannabis or cannabidiol. These unique DIY DabTabsTM kits position Halo and High Tide as industry leaders penetrating the home preparation market. The partnership will generate distribution of this product throughout Canada, USA and Europe, and will be the first of many products that the companies will launch jointly.
Kiran Sidhu, CEO of Halo Labs, commented: “I am truly excited about this partnership that will strengthen Halo’s presence within the United States and expand its reach into Canada and Europe. This introduction to international markets is laying the groundwork for the Company to obtain access to the world, while providing Halo branded products directly to the consumer. With Halo being the product producer and High Tide being the hardware provider, the potential is endless.”
Raj Grover, President and Chief Executive Officer of High Tide Inc. added: “We are very excited to work with Halo as a leader in cannabis concentrates and other cannabis derivative products, including the innovative DabTabsTM. Our strengths in e-commerce through Grasscity.com and global wholesale distribution network are a great fit for this exclusive partnership with Halo and their portfolio of growth initiatives.”
Based in Amsterdam since 2000, Grasscity.com is the world’s preeminent and most searchable online retailer of smoking accessories and cannabis lifestyle products with approximately 5.8 million site visits annually.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com – News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Join To Our Newsletter
You are welcome